Akums Drugs and Pharmaceutical (AKUMS) — Working Capital to Net Assets Ratio
Akums Drugs and Pharmaceutical (AKUMS) has a Working Capital to Net Assets ratio of 77.7% as of September 2025. Working capital of Rs24.61 Billion (current assets of Rs32.93 Billion minus current liabilities of Rs8.33 Billion) is measured against net assets of Rs31.68 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See AKUMS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Akums Drugs and Pharmaceutical Working Capital to Net Assets (2022–2025)
This chart shows how Akums Drugs and Pharmaceutical's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the ratio stands at 77.7%, reflecting working capital of Rs24.61 Billion against net assets of Rs31.68 Billion INR. See AKUMS defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Akums Drugs and Pharmaceutical (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Akums Drugs and Pharmaceutical from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Akums Drugs and Pharmaceutical.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.1% | Rs13.81 Billion | Rs30.64 Billion | Rs22.75 Billion | Rs8.94 Billion | ▼ -56.3 pp |
| 2024 | 101.4% | Rs7.30 Billion | Rs7.20 Billion | Rs19.41 Billion | Rs12.11 Billion | ▲ +10.3 pp |
| 2023 | 91.0% | Rs6.59 Billion | Rs7.23 Billion | Rs19.24 Billion | Rs12.66 Billion | ▼ -8.0 pp |
| 2022 | 99.0% | Rs6.19 Billion | Rs6.25 Billion | Rs18.92 Billion | Rs12.72 Billion | — |